Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.

ABSTRACT: The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) obtained a sample of 1493 chronic schizophrenia patients. The European First Episode Schizophrenia Trial (EUFEST) studied a sample of 498 patients. We have combined these two samples to study the predictors and correlates of adherence to treatment. Here we report on adherence to pharmacological treatment at the six and twelve month assessments of these trials with a combined subsample of 1154 schizophrenia patients. Individual patients׳ data were used for analyses. We used logistic regression to examine the effects of substance use, akathisia, parkinsonism, dyskinesia, hostility, and insight on pharmacological adherence. The results showed that reduced adherence to pharmacological treatment was associated with substanc

SUBMITTER: Czobor P 

PROVIDER: S-EPMC4860611 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature